Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Denmark issues reminder on breast implants

This article was originally published in Clinica

The increase in the number of breast implant operations in Denmark - currently some 2,000 annually - as a result of reconstructive surgery and for cosmetic purposes has prompted the national board of health and welfare, Sundhedsstyrelsen, to issue a warning about the risks involved.

There are certain situations where the insertion of breast implants is not recommended, says the board. These include if: cancer has been diagnosed; an active infection has been detected; a woman has been suffering from an auto-immune disease; or a woman is either pregnant or breast feeding. Many patients are not aware of complications that may occur after an operation, including a loss of sensation, swelling, tissue irritation and bleeding, adds the board.

Furthermore, there is evidence that breast implants can adversely affect mammography. Because X-rays are sometimes unable to penetrate silicone and saline prostheses, there can be problems in identifying a tumour.

There is still a possibility of identifying a tumour if the gland tissue covers the implant, but this is often made more difficult by the possible development of calcium deposits around the prosthesis, says the board. This often leads to unnecessary biopsy, it adds.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel